Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A...
Conference

SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A ANTIBODY PF-06480605 IN TREATMENT OF ULCERATIVE COLITIS: THE OPEN-LABEL, MULTICENTER, PHASE 2A TUSCANY STUDY

Authors

Danese S; Klopocka M; Scherl EJ; Romatowski JA; Allegretti JR; Peeva E; Vincent MS; Schoenbeck U; Xi L; Ye Z

Volume

158

Pagination

pp. S206-S207

Publisher

W B SAUNDERS CO-ELSEVIER INC

Publication Date

5 2020

Name of conference

Crohn's and Colitis Congress

Conference place

TX, Austin

Conference start date

January 23, 2020

Conference end date

January 25, 2020

Conference proceedings

GASTROENTEROLOGY

Issue

6

ISSN

0016-5085